human adipose-derived mesenchymal stem cell
/ Beijing Aige Stem Cell Technology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 31, 2026
Clinical Study on Safety, Tolerability, and Preliminary Efficacy of Local Injection of Human Adipose-Derived Mesenchymal Stem Cell Injection for Focal Scleroderma and Skin Hardening in the Head, Face, and Limbs
(ChiCTR)
- P=N/A | N=17 | Not yet recruiting | Sponsor: Peking Union Medical College Hospital; Peking Union Medical College Hospital
New trial • Immunology • Scleroderma • Systemic Sclerosis
1 to 1
Of
1
Go to page
1